Foundation Leader Honored with National Award

Danvers, Massachusetts. May 9, 2023

The Board of Directors of the National Scleroderma Foundation is pleased to congratulate Carol Feghali-Bostwick, Ph.D. for her receipt of the Translational Science Award from the Association for Clinical and Translational Science (ACTS).

Dr. Feghali-Bostwick, along with colleague ReJoyce Green, Ph.D., received the award on April 18 at the Translational Science Conference in Washington, DC. Dr. Feghali-Bostwick was recognized “for contributing to the diversity and inclusiveness of the translational workforce.” ACTS President Linda B. Cottler, Ph.D. stated, “The ACTS awards recognize talented investigators who translate their findings ultimately from the bench to the community. Awardees are in all phases of studies and disciplines throughout the workforce, which includes investigators, trainees, educators, and research teams as well as the advancement of diversity, inclusion, and health equity.”

Carol Feghali-Bostwick, Ph.D., was recruited to the Medical University of South Carolina Division of Rheumatology and Immunology in 2013 as the SmartState and Kitty Trask Holt Endowed Chair and Professor of Medicine. Dr. Feghali-Bostwick earned her Ph.D. in Microbiology and Immunology at Tulane University in New Orleans, Louisiana. At MUSC, Dr. Feghali-Bostwick leads a team of clinical and basic scientists focusing on the pathogenic mechanisms underlying fibrosis whose goal is to identify novel targets for therapy and develop new anti-fibrotic strategies for scleroderma/systemic sclerosis, idiopathic pulmonary fibrosis, and other fibrosing conditions. Dr. Feghali-Bostwick also contributes to the mentoring of young physicians and academic scientists. She serves as Vice Chair of the Board of Directors for the National Scleroderma Foundation and is also Chair of the Research Committee and liaison to the Medical and Scientific Advisory Committee.

To learn more about Dr. Feghali-Bostwick and this high honor, please visit

About the National Scleroderma Foundation

A relentless force in finding a cure and improving the lives of people affected by scleroderma, the National Scleroderma Foundation advances medical research, promotes disease awareness, and provides support and education to people with scleroderma, their families and support networks. Supported by a network of thousands of individuals across the United States, the Foundation is the leading nonprofit funder of peer-reviewed research to discover the cause, understand the mechanisms, and overcome scleroderma forever. National Scleroderma Foundation has been recognized for its commitment to financial transparency and reporting with six consecutive years of four-star ratings by Charity Navigator, and a platinum seal of approval  by Candid. For more information, visit